Found 58 matching trials
MDT-bridged Radical Therapy After Aumolertinib With MRD-guided Maintenance in EGFRm+ Unresectable Stage III NSCLC (APPROACH)
PHASE3This is an open-label, multi-center, randomized, phase III study. It is aim...
Status
Active Not Recruiting
Location
Guangdong Lung cancer institute
Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer
NAThis is a single-arm, interventional study to explore the feasibility of ci...
Status
Active Not Recruiting
Location
Qilu Hospital of Shandong Univertisy
Research on Colorectal Cancer Recurrence Monitoring and Individualized Treatment Based on MRD
NAThis study aims to evaluate whether plasma molecular residual disease (MRD)...
Location
Sun Yat-sen University Cancer Center
Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)
PHASE2The goal of this Clinical Study is to understand the outcomes by informing ...
Location
University of Alabama at Birmingham
The Value of Molecular Residual Disease Monitoring Based on ctDNA in Resected Pancreatic Cancer
NAThe goal of this clinical trial is to explore the value of molecular residu...
Location
Department of Medical Oncology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer
PHASE2To further validate the performance of the high-sensitivity MRD assay in pa...
Location
Cancer hospital, CAMS
Pirtobrutinib and Venetoclax With MRD Detection for Previously Untreated Chronic Lymphocytic Leukemia
PHASE2This phase II trial studies how well pirtobrutinib and venetoclax work in t...
Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Minimal Residual Disease Guiding Adjuvant Therapy in Stage I NSCLC
NAThis investigator-initiated study aims to evaluate the effectiveness of min...
Location
Dongguan People's Hospital
Signatera Assessment in Early-Stage Endometrial Cancer
NAThe goal of this clinical trial is to assess if circulating tumor DNA can g...
Location
University of Alabama at Birmingham Hospital
A Study of MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-NaΓ―ve, High-Risk CLL/SLL Patients
PHASE2This study is a prospective, multicenter, open-label, single-arm phase II c...
Location
Jiangsu Province Hospital